Hydroxychloroquine: is there a role in long COVID?
Clin Rheumatol
.
2023 Mar;42(3):977-978.
doi: 10.1007/s10067-023-06514-x.
Epub 2023 Jan 25.
Authors
Samuel S Y Wang
#
1
,
Chuanhui Xu
#
2
Affiliations
1
Rheumatology, Allery and Immunology, Tan Tock Seng Hospital, Singapore, Singapore.
2
Rheumatology, Allery and Immunology, Tan Tock Seng Hospital, Singapore, Singapore. xuchuanhui2008@gmail.com.
#
Contributed equally.
PMID:
36695924
PMCID:
PMC9874177
DOI:
10.1007/s10067-023-06514-x
No abstract available
Publication types
Letter
MeSH terms
Antimalarials* / therapeutic use
COVID-19 Drug Treatment
COVID-19*
Humans
Hydroxychloroquine / adverse effects
Post-Acute COVID-19 Syndrome
Substances
Hydroxychloroquine
Antimalarials